Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
NCT05802329
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Center Involved Diabetic Macular Edema
- Diabetic Macular Edema
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Ocugen
- Last updated on ClinicalTrials.gov
- July 31, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Advanced Research LLC · Deerfield Beach, FL
Pennsylvania · 1
- Erie Retina Research, LLC · Erie, PA
Texas · 2
- Retina Consultants of Texas Research Centers · Bellaire, TX
- Retina Consultants of America · Southlake, TX
Wisconsin · 1
- Gundersen Health System · La Crosse, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.